Latest News

 Filter by Provider

On-chain data shows the Bitcoin Network Value to Transactions (NVT) Golden Cross has plummeted recently. Here’s what this could mean for BTC’s price.

The Potomac Energy Center deal is Blackstone’s most recent investment in the power infrastructure supporting data centers and the AI revolution—one of the firm’s highest-conviction areas.

Wall Street is expecting Microsoft's sales and earnings growth to slow when it posts fiscal Q2 results Wednesday. Microsoft stock dipped.

ERIC earnings call for the period ending December 31, 2024.

Lexington-based Valo Health is one of the pioneering players in the AI-drug discovery market.

NEE earnings call for the period ending December 31, 2024.

There was some tepid good news as to existing home sales in December, which have been flat in the general range of 3.85 -4.10 million annualized for almost two years.

The FolioBeyond Enhanced Fixed Income Premium ETF offers innovative strategies for diversification and income generation with a focus on risk-adjusted returns.

Despite concerns about iPhone demand, analyst remains bullish on Apple's earnings potential. Services growth and margins keep outlook positive.

TransCode Therapeutics Inc. (NASDAQRNAZ) shares are moving higher Friday after the company announced that the first patient in Cohort 3 of its Phase 1 clinical trial has been dosed with its lead candidate, TTX-MC138 on Tuesday.

A new poll reveals whether investors think Warren Buffett will sell more Apple stock on the heels of China iPhone demand concerns.

Goldman Sachs analyst optimistic about cruise line industry after successful Q3. Royal Caribbean and Norwegian Cruise Line ratings and price targets lowered.

NVIDIA shares are moving lower on Friday following soft guidance from Texas Instruments.

Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved investor sentiment likely.

JPMorgan’s Mark Murphy was “incrementally constructive” on Twilio’s profitability growth, while Morgan Stanley analysts also walked away similarly “encouraged.”

NextEra Energy reports Q4 results, with revenue missing estimate. Expects continued growth and dividend increases through 2027.

The agreement, which spans up to four years, allows 17 participating countries access to Moderna’s vaccine in various formats.

Stock market rally faces reality check as equity risk premium turns negative, sparking debates about potential overvaluation and potential echoes of dot-com bubble.

Stocks are sluggish to end an otherwise outstanding week on Wall Street. 

On an adjusted basis, the company reported fourth-quarter net earnings of $45.10 per share, compared with the market estimate of $39.11 per share, according to Koyfin data.

TikTok's fate remains uncertain as Apple, Google, and Oracle have differing approaches due to their interests. Trump's support for Oracle and potential buyers adds to the drama.

Merck and Eisai report mixed results from LEAP-015 trial of Keytruda and Lenvima in HER2-negative gastroesophageal cancer treatment.

Perspective Therapeutics shares interim results for [212Pb]VMT-α-NET trial, showing promising safety, stable disease cases, and anti-tumor activity.

Twilio's stock has surged due to its advancements in AI and strategic financial initiatives, including a $2 billion share buyback plan.

JP Morgan analyst maintains Overweight rating on Qualcomm, as Samsung's flagship S25 uses Snapdragon chips, increasing Qualcomm's revenue and EPS.

Bank of Japan (BOJ) lifted the benchmark borrowing cost to the highest in 17 years while raising inflation forecasts.

Shares of analog chip manufacturer Texas Instruments (NASDAQTXN) fell 5.9% in the morning session after the company reported underwhelming fourth-quarter results, with earnings guidance for the next quarter falling short of Wall Street's expectations. Adding to the negative was the fact that inventory levels increased, contributing to weaknesses in Japan and Europe, especially in the auto, and industrial markets. These weaknesses were partly offset by continued strength in China's auto and smartphone markets. These pockets of strength helped drive revenue and EPS past Wall Street's estimates during the quarter. Overall, we think this was a mixed quarter with guidance weighing on shares.